The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
Language English Country Netherlands Media print-electronic
Document type Journal Article, Review
PubMed
31451336
DOI
10.1016/j.atherosclerosissup.2019.08.023
PII: S1567-5688(19)30046-7
Knihovny.cz E-resources
- MeSH
- Biological Products adverse effects pharmacokinetics therapeutic use MeSH
- Biotransformation MeSH
- Cholesterol blood MeSH
- Cytochrome P-450 CYP3A metabolism MeSH
- Double-Blind Method MeSH
- Gastrointestinal Diseases chemically induced MeSH
- Hypercholesterolemia therapy MeSH
- Food-Drug Interactions MeSH
- Cardiovascular Diseases chemically induced MeSH
- Clinical Trials as Topic MeSH
- Humans MeSH
- Lovastatin adverse effects chemistry pharmacokinetics therapeutic use MeSH
- Molecular Structure MeSH
- Multicenter Studies as Topic MeSH
- Musculoskeletal Diseases chemically induced MeSH
- Dietary Supplements * MeSH
- Prodrugs pharmacokinetics therapeutic use MeSH
- Randomized Controlled Trials as Topic MeSH
- Self Medication MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects therapeutic use MeSH
- Medicine, Chinese Traditional MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Biological Products MeSH
- Cholesterol MeSH
- CYP3A4 protein, human MeSH Browser
- Cytochrome P-450 CYP3A MeSH
- Lovastatin MeSH
- Prodrugs MeSH
- red yeast rice MeSH Browser
- Hydroxymethylglutaryl-CoA Reductase Inhibitors MeSH
3rd Department of Medicine Charles University and General University Hospital Prague Czech Republic
Department of Internal Medicine University of Debrecen Faculty of Medicine Debrecen Hungary
Department of Nutrition Dietetics Harokopio University Athens Greece
National Medical Research Center of Cardiology of the Ministry of Health Moscow Russia
References provided by Crossref.org
